New Med For Adhd

Featured Article

Drugmaker Tergacept's experimental ADHD medication is being moved into late-stage clinical trails, according to the company. The drug--known as AZD3480 or TC-1734--has already completed mid-stage trials for ADHD, as well as for Alzheimer's and Schizophrenia. The medication is part of a new class of drugs called neuronal nicotinic receptor therapeutics, which are aimed at treating central nervous system disorders.

Read more

More information on "New Med For Adhd"

From Our Experts

See more SharePosts »

From Our Sources

More on ADHD »